Table 3:
Entity Linking Shared Tasks
| Domain | Year | Task | Document Source | Entity Type(s) | Ontology |
|---|---|---|---|---|---|
| Scientific Literature | 2004 | BC I (1b)[84] | MEDLINE | Fly, mouse, and yeast genes | Organizer provided |
| 2006 | BC II (1b)[85] | MEDLINE | Human genes | EntrezGene | |
| 2010 | BC III GN[86] | PMC full text | Genes | EntrezGene | |
| 2016 | BC V CDR (3a)[47] | PubMed | Chemicals, diseases, chemical-disease interactions | MeSH | |
| 2017 | BC VI Bio-ID (1)[54] | Figure captions | Genes, chemicals, cell type, subcellular location, tissue, organism | ||
| 2019 | BioNLP 2019 (1)[49] | PubMed | Microorganism, habitat, phenotype | NCBI, OntoBiotope | |
| 2021 | BC VII NLMCHEM (1b)[51] | PubMed | Chemicals | MeSH | |
| clinical | 2013 | ShARe/CLEF 2013 (1b,2)[14] | Clinical records | Disorders | SNOMED CT |
| 2014 | SE-2014 (7b)[87] | Disorders | SNOMED CT | ||
| 2015 | SE-2015 Task 14 (1,2a)[88] | Disorders | SNOMED CT | ||
| 2019 | 2019 n2c2 (3)[56] | Problems, treatments, tests | SNOMED CT, RxNorm | ||
| 2019 | PharmaCoNER[50] | Clinical records | Drugs, chemicals | SNOMED CT | |
| 2020 | IberLEF CANTEMIST-NORM[58] | (ESP) | Tumor morphology | ICD-O | |
| social Media | 2017 | SMM4H 2017 (3)[62] | ADRs | MedDRA | |
| 2017 | TAC 2017[60] | Drug labels | ADRs | MedDRA |
BioCreative (BC); SemEval (SE); Task/Track number in parentheses